These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16438082)

  • 1. Development of early malignant bilateral breast disease in relation to antidepressant treatment.
    Markopoulos C; Kouskos E; Phillipidis T
    Acta Chir Belg; 2005; 105(6):660-1. PubMed ID: 16438082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast enlargement during chronic antidepressant therapy.
    Amsterdam JD; Garcia-España F; Goodman D; Hooper M; Hornig-Rohan M
    J Affect Disord; 1997 Nov; 46(2):151-6. PubMed ID: 9479619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant use during pregnancy. FPIN’s clinical inquiries.
    Patel BN; Beste J; Blackwell JC
    Am Fam Physician; 2011 May; 83(10):1211-5. PubMed ID: 21568258
    [No Abstract]   [Full Text] [Related]  

  • 4. Syndrome of inappropriate ADH secretion attributed to the serotonin re-uptake inhibitors, venlafaxine and paroxetine.
    Meynaar IA; Peeters AJ; Mulder AH; Ottervanger JP
    Neth J Med; 1997 Jun; 50(6):243-5. PubMed ID: 9232089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: intraindividual variability and plasma concentration correlations.
    Alfaro CL; Lam YW; Simpson J; Ereshefsky L
    J Clin Pharmacol; 2000 Jan; 40(1):58-66. PubMed ID: 10631623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe hypertriglyceridemia secondary to venlafaxine and fluoxetine.
    Teitelbaum M
    Psychosomatics; 2001; 42(5):440-1. PubMed ID: 11739916
    [No Abstract]   [Full Text] [Related]  

  • 7. Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects.
    Kennedy SH; McCann SM; Masellis M; McIntyre RS; Raskin J; McKay G; Baker GB
    J Clin Psychiatry; 2002 Mar; 63(3):181-6. PubMed ID: 11926715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: Severe anticholinergic side effects with venlafaxine-fluoxetine combination.
    Zedkova L; Coupland NJ
    Can J Psychiatry; 1998 Jun; 43(5):523. PubMed ID: 9653539
    [No Abstract]   [Full Text] [Related]  

  • 9. Antidepressant discontinuation: a review of the literature.
    Lejoyeux M; Adès J
    J Clin Psychiatry; 1997; 58 Suppl 7():11-5; discussion 16. PubMed ID: 9219488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
    Hjalmarsson L; Corcos M; Jeammet P
    Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?
    Bateman DN; Chick J; Good AM; Kelly CA; Masterton G
    Eur J Clin Pharmacol; 2004 May; 60(3):221-4. PubMed ID: 15083251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight gain and associated factors in patients using newer antidepressant drugs.
    Uguz F; Sahingoz M; Gungor B; Aksoy F; Askin R
    Gen Hosp Psychiatry; 2015; 37(1):46-8. PubMed ID: 25467076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine.
    Gibbons RD; Brown CH; Hur K; Davis J; Mann JJ
    Arch Gen Psychiatry; 2012 Jun; 69(6):580-7. PubMed ID: 22309973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Selective serotonin reuptake inhibitors and mammary pathologies].
    Shchepotin IB; Zotov AS; Dobzhenko MN
    Vopr Onkol; 2010; 56(4):393-7. PubMed ID: 20968014
    [No Abstract]   [Full Text] [Related]  

  • 15. [Malignant neuroleptic syndrome and serotoninergic syndrome: two cases].
    Bruscas Alijarde MJ; de Benito Cordón L; García Mateos D; Ruiz Clemente M; Hervás Laguna MJ
    Rev Clin Esp; 2007; 207(7):374-5. PubMed ID: 17662207
    [No Abstract]   [Full Text] [Related]  

  • 16. Serotonin reuptake inhibitors in Raynaud's phenomenon.
    Jaffe IA
    Lancet; 1995 May; 345(8961):1378. PubMed ID: 7752794
    [No Abstract]   [Full Text] [Related]  

  • 17. Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study.
    Brent DA; Emslie GJ; Clarke GN; Asarnow J; Spirito A; Ritz L; Vitiello B; Iyengar S; Birmaher B; Ryan ND; Zelazny J; Onorato M; Kennard B; Mayes TL; Debar LL; McCracken JT; Strober M; Suddath R; Leonard H; Porta G; Keller MB
    Am J Psychiatry; 2009 Apr; 166(4):418-26. PubMed ID: 19223438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response.
    Asarnow JR; Emslie G; Clarke G; Wagner KD; Spirito A; Vitiello B; Iyengar S; Shamseddeen W; Ritz L; Birmaher B; Ryan N; Kennard B; Mayes T; DeBar L; McCracken J; Strober M; Suddath R; Leonard H; Porta G; Keller M; Brent D
    J Am Acad Child Adolesc Psychiatry; 2009 Mar; 48(3):330-339. PubMed ID: 19182688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the efficacy and safety of fluoxetine and venlafaxine in outpatient depression.
    Michelson D
    J Clin Psychiatry; 1999 May; 60(5):338-40. PubMed ID: 10362446
    [No Abstract]   [Full Text] [Related]  

  • 20. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.
    Kennedy SH; Eisfeld BS; Dickens SE; Bacchiochi JR; Bagby RM
    J Clin Psychiatry; 2000 Apr; 61(4):276-81. PubMed ID: 10830148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.